APA (7th ed.) Citation

Terpos, E., Ntanasis‐Stathopoulos, I., Malandrakis, P., Fotiou, D., Migkou, M., Eleutherakis‐Papaiakovou, E., . . . Kastritis, E. Increased serum B‐cell maturation antigen levels evaluated with an Elecsys‐based serum B‐cell maturation antigen assay have a negative prognostic value in patients with newly diagnosed multiple myeloma. Wiley.

Chicago Style (17th ed.) Citation

Terpos, Evangelos, et al. Increased Serum B‐cell Maturation Antigen Levels Evaluated with an Elecsys‐based Serum B‐cell Maturation Antigen Assay Have a Negative Prognostic Value in Patients with Newly Diagnosed Multiple Myeloma. Wiley.

MLA (9th ed.) Citation

Terpos, Evangelos, et al. Increased Serum B‐cell Maturation Antigen Levels Evaluated with an Elecsys‐based Serum B‐cell Maturation Antigen Assay Have a Negative Prognostic Value in Patients with Newly Diagnosed Multiple Myeloma. Wiley.